170 related articles for article (PubMed ID: 3024991)
1. Emetic and antiemetic effects of opioids in the dog.
Blancquaert JP; Lefebvre RA; Willems JL
Eur J Pharmacol; 1986 Sep; 128(3):143-50. PubMed ID: 3024991
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
3. Enkephalin receptors in the emetic chemoreceptor trigger zone of the dog.
Bhargava KP; Dixit KS; Gupta YK
Br J Pharmacol; 1981 Mar; 72(3):471-5. PubMed ID: 6266566
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
5. The actions of fentanyl to inhibit drug-induced emesis.
Barnes NM; Bunce KT; Naylor RJ; Rudd JA
Neuropharmacology; 1991 Oct; 30(10):1073-83. PubMed ID: 1661861
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
[TBL] [Abstract][Full Text] [Related]
7. Antiaversive properties of opioids in the conditioned taste aversion test in the rat.
Blancquaert JP; Lefebvre RA; Willems JL
Pharmacol Biochem Behav; 1987 Jul; 27(3):437-41. PubMed ID: 2821551
[TBL] [Abstract][Full Text] [Related]
8. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine.
Foss JF; Yuan CS; Roizen MF; Goldberg LI
Cancer Chemother Pharmacol; 1998; 42(4):287-91. PubMed ID: 9744773
[TBL] [Abstract][Full Text] [Related]
9. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
10. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
11. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
Iwamoto ET
Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
14. Response of rat globus pallidus neurons to microintophoretically applied mu and kappa opioid receptor agonists.
Huffman RD; Frey JM
Eur J Pharmacol; 1989 Nov; 170(3):179-91. PubMed ID: 2575994
[TBL] [Abstract][Full Text] [Related]
15. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
[TBL] [Abstract][Full Text] [Related]
16. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
Dray A; Metsch R
Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
[TBL] [Abstract][Full Text] [Related]
17. [Emetic and antiemetic properties of regulatory peptides].
Iasnetsov VV; Drozd IuV; Shashkov VS
Biull Eksp Biol Med; 1987 May; 103(5):586-8. PubMed ID: 2439138
[TBL] [Abstract][Full Text] [Related]
18. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
Rathbun RC; Kattau RW; Leander JD
Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
[TBL] [Abstract][Full Text] [Related]
19. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
Gué M; Junien JL; Bueno L
J Pharmacol Exp Ther; 1989 Sep; 250(3):1006-10. PubMed ID: 2550612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
